VXRT - חוב כולל להון Vaxart

The daily price chart for Vaxart, Inc. (VXRT) based on the debt load metric is 0.00. Vaxart, Inc. is optimizing drug delivery by developing tablet-based vaccines, which eliminates cold-chain transportation costs. The company plans to generate revenue through large-scale government contracts for the supply of norovirus and influenza treatments. Currently, the business relies on external investments and grants as its developments remain in the testing phase.

This ratio is critical for stress-testing debt load and assessing the issuer's financial stability during periods of rate volatility. Analyzing the total debt-to-equity ratio determines the volume of borrowed funds per unit of net assets, while low total debt-to-equity values confirm the ability of Vaxart, Inc. (VXRT) to develop its proprietary oral vaccine platform without excessive credit pressure.